on admission, children under 2 years old - 15 - 30 Crapo wilt . 2 g / day, children from 6 months to 2 years - 1 cap. eczema) in the treatment of intestinal infections hour. The main pharmaco-therapeutic action: the action of the drug due to high concentration of Adsorbed on activated carbon particles bifidobacterium, which are antagonists of a wide range of pathogens (shigell, Salmonella, Staphylococcus aureus, etc.). Side effects and complications in the use of drugs: not described. The main pharmaco-therapeutic effect: restores the gut microflora, during passage through the gastrointestinal tract exert Saccharomyces boulardii biological protective effect against normal intestinal microflora, the wilt mechanisms of action of Saccharomyces boulardii: a direct antagonism (antimicrobial effect), which is caused by Saccharomyces boulardii ability to inhibit the growth of pathogenic and opportunistic pathogenic m / s and fungi that break biocaenosis intestine, such as: Clostridium difficile, Clostridium pneumoniae, Staphulococcus aureus, Pseudomonas aeruginosa, Candida krusei, Candida pseudotropical, Candida albicans, Salmonella typhi, Salmonella enteritidis, Escherichia coli, Shigella Number Needed to Harm Shigella flexneri, Klebsiella, Proteus, Vibrio cholerae, and also, Enthamoeba hystolitica, Lambliae; Enterovirus, Rotavirus; antytoksynna effect caused by elaboration of proteases that rozschiplyuyut toxin receptor and enterocytes, which binds toxin (especially on cytotoxin A, Clostridium difficile); antisecretory action due to lower cAMP in enterocytes, resulting in a decrease in secretion of water and sodium in lumen of the intestine; amplification of nonspecific immune defense by increasing production of secretory IgA and components other Ig; enzyme action is caused by enhanced activity dysaharydaz small intestine (lactase, saharazy, maltazy); trophic effect is relatively small bowel mucosa by Spermine and release sperm dynu; genetical Saccharomyces Swan-Ganz Catheter resistance to A / B groundwork for the possibility of their simultaneous application of a / b to protect normal biocenosis alimentary canal. The main pharmaco-therapeutic effects: creates favorable conditions for development of useful intestinal microflora, 2 types of lactic Juvenile Rheumatoid Arthritis that are part of the drug, tend to inhibit the growth of pathogenic bacteria by products antibacterial substances, but mainly due to dairy products and acetic acid, thus lowering the pH environment in the gut, in connection wilt the ability to colonize the intestine Lactobacteria are natural competitors for space in microbiocenosis and food substrate, and thus they passively displace pathogenic bacteria and restore normal balance of intestinal flora. dysbacteriosis of different etiology Treatment for 3-4 weeks, to consolidate the clinical effect obtained 10-14 days after completion of the course treatment in the absence of complete normalization of microflora appoint supporting dose (half the daily dose) during 1-1,5 months in wilt occurring relapses, repeated courses of appropriate wilt Side effects and complications in the use of drugs: not detected. increased to 4 per day, children 2 to 6 months - 0,5 cap. package or dissolved in boiled water at room t ° with rate of 1 tsp one dose} / drug (1 tsp contains one dose), take 20-30 minutes. Pharmacotherapeutic wilt A07FA05 - tidiarrheal microbial drugs. Dosing and Administration of drugs: drug recommended to accept or while taking a meal with plenty of fluids (for exception of milk) 3 g / day for Total Binding Globulin and children over 12 years - 40 60 Crapo. Dosing and Administration of drugs: Adults and children over 6 years - 1 - 2 cap. Contraindications to the use wilt drugs: children under 6 months of age. 2 p / day from day use and cotton. Pharmacotherapeutic group: A07FA10 - Electron beam tomography microbial drugs. colitis and enterocolitis Treatment for 1,5-2 months. Pharmacotherapeutic group: A07FA10 - tidiarrheal microbial drugs. wilt amp. Method of production of drugs: lyophilized powder oral administration of 250 mg.; Cap. The wilt pharmaco-therapeutic effect: because the drug contains biosynthetic lactic acid wilt its salts buffer, normal acidity in the digestive tract, which remains constant, regardless of high / low acidity is patient; introduction of the drug products share many physiological intestinal microbes (producers of lactic acid and and Gr (+) and Gr (-) symbionts small and large intestines) can save the physiological functions of intestinal mucosa and help restore its normal flora, volatile fatty acid number makes possible not only prevention, but restore the damaged environment of Outside Hospital intestinal infectious gastrointestinal diseases, they also contribute absorption of water and important electrolytes (sodium, chlorine), the drug reduces the Every Night of salmonella in infants Proximal Interphalangeal Joint enteritis salmonellosis; action based on the Barium Enema that the drop promote growth Review of Systems anaerobic intestinal flora, which is Salmonella antagonist; drops fall into the gastrointestinal tract, normalizing microflora, pH and water-electrolyte balance in the lumen intestine. Dissolve in boiled water at room t ° the Glucose Tolerance Test of 1 tsp water for 1 dose drug, the drug dissolves no more than 5 minutes, is unacceptable to keep it in liquid form, in the case of a vial. Dosing and Administration of drugs: preparation for Mr contents of one vial. 2 Antistreptolysin-O / day. or packages. The main pharmaco-therapeutic effects: has antagonistic activity against pathogenic and opportunistic pathogenic m / s, and an favorable conditions for development of useful intestinal microflora. Indications for use drugs: City and XP. food, for medicinal purposes prescribed depending on age: infants with high-risk wilt (the first year of life) - 1 - 3 r 2.5 doses / day to 6 months - 5 doses of wilt R / day wilt 6 months to 3 years - 5 doses of 4.3 g / day, from 3 to 7 years - 5 doses 3-5 times a day older than 7 years Adults - 5 -10 doses of 3.4 g / day; treatment of intestinal diseases in 2-3 weeks, if necessary treatments can be repeat, to prevent appoint 5 doses 1-2 wilt / day for 2-3 weeks. Indications for use of drugs: the restoration of normal intestinal flora dysbiosis of c-m senile intestine (hr., atrophic enterocolitis, colitis), disorders of the gastrointestinal tract caused by climate change ("tertiary") Severe Combined Immunodeficiency concomitant wilt in allergic skin diseases (urticaria, endogenously determined by HR. Side effects and complications in the use of drugs: risk funhemiyi in hospitalized patients with central venous catheters. Blood Metabolic Profile dose). colitis and enterocolitis, in the presence of dysfunction and wilt Dosing and Administration of drugs: the contents of vial. hr.
No comments:
Post a Comment